Advertisement

Canadian Journal of Public Health

, Volume 105, Issue 1, pp e69–e78 | Cite as

The economic benefits of risk factor reduction in Canada: Tobacco smoking, excess weight and physical inactivity

  • Hans KruegerEmail author
  • Donna Turner
  • Joshua Krueger
  • A. Elizabeth Ready
Quantitative Research
  • 2 Downloads

Abstract

OBJECTIVE: Tobacco smoking, excess weight and physical inactivity contribute substantially to the preventable disease burden in Canada. The purpose of this paper is to apply a recently developed approach in addressing the issue of double counting in estimating the combined current economic burden of these risk factors (RFs) and to estimate the economic benefits of long-term RF reduction in Canada.

METHODS: We used an approach based on population attributable fractions (PAF) to estimate the economic burden associated with the various RFs. Sex-specific relative risk and age-/sex-specific prevalence data were used in the modelling when available. Excess weight was modelled as a trichotomous exposure (normal weight, overweight, obese) while tobacco smoking was modelled as a tetrachotomous exposure (non-smoker, light, medium or heavy smoker). All costs are given in constant 2012 Canadian dollars.

RESULTS: The annual economic burden of the RFs of tobacco smoking, excess weight and physical inactivity in Canada are estimated at $50.3 billion in 2012. Sensitivity analysis suggests a range for the economic burden of $41.6 to $58.7 billion. Of the $50.3 billion, $21.3 ($20.0 to $22.6) billion is attributable to tobacco smoking, $19.0 ($1 3.8 to $24.0) billion to excess weight and $10.0 ($7.8 to $12.0) billion to physical inactivity. A 1 % relative annual reduction in each of the three RFs would result in an $8.5 billion annual reduction in economic burden by 2031.

CONCLUSION: A modest annual 1 % relative reduction in the RFs of tobacco smoking, excess weight and physical inactivity can have a substantial health and economic impact over time at the population level.

Key words

Economic burden population attributable fraction risk factors tobacco smoking excess weight physical inactivity 

Résumé

OBJECTIF: Le tabagisme, le surpoids et la sédentarité alourdissent beaucoup le fardeau des maladies évitables au Canada. Nous avons appliqué une démarche élaborée récemment afin d’aborder le problème du double comptage dans l’estimation du fardeau économique actuel combiné de ces trois facteurs de risque et d’estimer les avantages économiques de la réduction à long terme des facteurs de risque au Canada.

MÉTHODE: Notre démarche se fonde sur les fractions attribuables dans la population (FAP) pour estimer le fardeau économique associé aux divers facteurs de risque. Lorsqu’elles étaient disponibles, nous avons utilisé des données sur le risque relatif selon le sexe et des données de prévalence selon l’âge et le sexe pour la modélisation. Le surpoids a été modélisé en tant qu’exposition trichotome (sujet de poids normal, en surpoids, obèse), et le tabagisme, en tant qu’exposition tétrachotome (non-fumeur, fumeur léger, fumeur moyen, grand fumeur). Tous les coûts sont en dollars canadiens constants de 2012.

RÉSULTATS: Le fardeau économique annuel des facteurs de risque du tabagisme, du surpoids et de la sédentarité au Canada est estimé à 50,3 milliards de dollars en 2012. L’analyse de sensibilité suggère un intervalle de 41,6 à 58,7 milliards de dollars pour le fardeau économique. Sur ces 50,3 milliards, 21,3 (20 à 22,6) sont imputables au tabagisme, 19 (13,8 à 24) au surpoids et 10 (7,8 à 12) à la sédentarité. Une baisse annuelle relative de 1 % de chacun des trois facteurs entraînerait une réduction annuelle du fardeau économique de 8,5 milliards de dollars d’ici 2031.

CONCLUSION: Une modique baisse annuelle relative de 1 % dans les facteurs de risque du tabagisme, du surpoids et de la sédentarité peut avoir un impact sanitaire et économique considérable au fil du temps au niveau de la population.

Mots clés

fardeau économique fraction attribuable dans la population facteurs de risque tabagisme surpoids sédentarité 

References

  1. 1.
    Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368(4):341–50.CrossRefGoogle Scholar
  2. 2.
    Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: A prospective study of one million women in the UK. Lancet 2013;381(9861):133–41.CrossRefGoogle Scholar
  3. 3.
    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224–60.CrossRefGoogle Scholar
  4. 4.
    Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med 2013;368(4):389–90.CrossRefGoogle Scholar
  5. 5.
    Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368(4):351–64.CrossRefGoogle Scholar
  6. 6.
    Gotay CC, Katzmarzyk PT, Janssen I, Dawson MY, Aminoltejari K, Bartley NL. Updating the Canadian obesity maps: An epidemic in progress. Can J Public Health 2013;104(1):e64–e68.Google Scholar
  7. 7.
    Withrow D, Alter DA. The economic burden of obesity worldwide: A systematic review of the direct costs of obesity. Obes Rev 2011;12(2):131–41.CrossRefGoogle Scholar
  8. 8.
    Katzmarzyk PT, Gledhill N, Shephard RJ. The economic burden of physical inactivity in Canada. CMAJ 2000;163(11):1435–40.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Katzmarzyk PT, Janssen I. The economic costs associated with physical inactivity and obesity in Canada: An update. Can J Appl Physiol 2004;29(1):90–115.CrossRefGoogle Scholar
  10. 10.
    Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH. The cost of obesity in Canada. CMAJ 1999;160(4):483–88.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Anis AH, Zhang W, Bansback N, Guh DP, Amarsi Z, Birmingham CL. Obesity and overweight in Canada: An updated cost-of-illness study. Obes Rev 2010;11(1):31–40.CrossRefGoogle Scholar
  12. 12.
    Kaiserman MJ. The cost of smoking in Canada, 1991. Chronic Dis Can 1997;18(1):13–19.PubMedGoogle Scholar
  13. 13.
    Moffatt E, Shack LG, Petz GJ, Sauvé JK, Hayward K, Colman R. The cost of obesity and overweight in 2005: A case study of Alberta, Canada. Can J Public Health 201;102(2):144-48.Google Scholar
  14. 14.
    Janssen I, Lam M, Katzmarzyk FT. Influence of overweight and obesity on physician costs in adolescents and adults in Ontario, Canada. Obes Rev 2009;10(1):51–57.CrossRefGoogle Scholar
  15. 15.
    Klein-Geltink JE, Choi BC, Fry RN. Multiple exposures to smoking, alcohol, physical inactivity and overweight: Prevalences according to the Canadian Community Health Survey Cycle 1.1. Chronic Dis Can 2006;27(1):25–33.PubMedGoogle Scholar
  16. 16.
    Krueger H, Williams D, Ready AE, Trenaman L, Turner D. Improved estimation of the health and economic burden of chronic disease risk factors in Manitoba, Canada. Chronic Dis Inj Can 2013;33(4):236–46.PubMedGoogle Scholar
  17. 17.
    Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.CrossRefGoogle Scholar
  18. 18.
    Wendel-Vos GC, Schuit AJ, Feskens EJ, Boshuizen HC, Verschuren WM, Saris WH, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 2004;33(4):787–98.CrossRefGoogle Scholar
  19. 19.
    Wolin KY, Yan Y, Colditz GA, Lee IM. Physical activity and colon cancer prevention: A meta-analysis. Br J Cancer 2009;100(4):611–16.CrossRefGoogle Scholar
  20. 20.
    Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. Lifestyle factors and colorectal cancer risk (1): Systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009;11(6):547–63.CrossRefGoogle Scholar
  21. 21.
    Walter SD. Local estimates of population attributable risk. J Clin Epidemiol 2010;63(1):85–93.CrossRefGoogle Scholar
  22. 22.
    Cole T, Bellizzi M, Flegal FC, Dietz W. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000;320(7244):1240–43.CrossRefGoogle Scholar
  23. 23.
    Canadian Community Health Survey 2010 Public Use Microdata file on CD-ROM (Catalogue number 82M0013XCB-2011000). All computations, use and interpretation of these data are entirely that of H. FCrueger & Associates Inc.Google Scholar
  24. 24.
    Hanley J. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001;55(7):508–14.CrossRefGoogle Scholar
  25. 25.
    Canadian Institute for Health Information. National Health Expenditure Trends, 1975–2012. Available at: https://www.secure.cihi.ca/free_products/NHEXTrendsReport2012EN.pdf (Accessed August 15, 2013).Google Scholar
  26. 26.
    Health Canada. The Economic Burden of Illness in Canada, 1998. 2002. Available at: http://www.publications.gc.ca/collections/Collection/H21-136-1998E.pdf (Accessed August 15, 2013).Google Scholar
  27. 27.
    Canadian Institute for Health Information. Hospital Morbidity Database, 2000/01 Tabular Results. Available at: https://www.secure.cihi.ca/free_products/HospitalMorbidityTabularReports2000-2001.pdf (Accessed August 15, 2013).Google Scholar
  28. 28.
    Statistics Canada. Population Projections for Canada, Provinces and Territories, 2009 to 2036, Catalogue No. 91-520-X, using the medium-growth–historical trends (1981 to 2008) scenario (M1), July 1st. Ottawa, ON: Statistics Canada, 2010.Google Scholar
  29. 29.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Hanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM 2001;344(18):1343–50.CrossRefGoogle Scholar
  30. 30.
    Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA 2008;299(17):2037–47.CrossRefGoogle Scholar
  31. 31.
    Rehm J, Ballunas D, Brochu S, Fischer B, Gnam W, Patra J, et al. The costs of substance abuse in Canada in 2002: Highlights. Canadian Centre on Substance Abuse. Available at: http://www.ccsa.ca/2006%20CCSA%20Documents/ccsa-011332-2006.pdf (Accessed May 10, 2013).Google Scholar
  32. 32.
    Janz T. Health at a glance: Current smoking trends. Statistics Canada Catalogue no. 82-624-X. Available at: http://www.statcan.gc.ca/pub/82-624-x/2012001/article/11676-eng.htm (Accessed May 10, 2013).Google Scholar
  33. 33.
    McLean D, Williams D, Lamont S, Krueger H. Community-based Prevention: Reducing the Risk of Cancer & Chronic Disease. Toronto, ON: University of Toronto Press, 2013.Google Scholar
  34. 34.
    Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Mannisto S, Sundvall J, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504–18.CrossRefGoogle Scholar
  35. 35.
    Puska P. The North Karelia Project: 30 years successfully preventing chronic disease. Diabetes Voice 2008;53:26–29.Google Scholar

Copyright information

© The Canadian Public Health Association 2014

Authors and Affiliations

  • Hans Krueger
    • 1
    • 2
    Email author
  • Donna Turner
    • 3
    • 4
  • Joshua Krueger
    • 2
  • A. Elizabeth Ready
    • 5
  1. 1.School of Population and Public HealthUniversity of British ColumbiaVancouverCanada
  2. 2.H. Krueger & Associates Inc.DeltaCanada
  3. 3.Department of Community Health SciencesUniversity of ManitobaWinnipegCanada
  4. 4.CancerCare ManitobaWinnipegCanada
  5. 5.Faculty of Kinesiology and Recreation ManagementUniversity of ManitobaWinnipegCanada

Personalised recommendations